Treatment burden is important to patients but often overlooked by clinicians

Dobler, Claudia C.

doi:10.1183/20734735.0031-2021

Cited by 7 publications

(4 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients with multiple chronic diseases are required to engage in various complex therapeutic and SM activities, which can increase the patient's treatment burden, thereby affecting SM adherence and subsequent outcomes. 33,34 In addition, patients often prefer to manage the symptomatic disease. 35 People with mild or moderate COPD usually have milder symptoms, which leads to non-prioritization of COPD.…”

Section: Copd Sm Behavior Among Persons With Mild-to-moderate Copdmentioning

confidence: 99%

Factors related to self-management behavior among persons with mild-to-moderate chronic obstructive pulmonary disease in Wenzhou, China

Sheng,

Samartkit,

Masingboon

2023

Frontiers of Nursing

View full text Add to dashboard Cite

Objective To describe the self-management (SM) behavior among persons with mild-to-moderate chronic obstructive pulmonary disease (COPD), and it examines the correlation between COPD knowledge, self-efficacy, perceived social support, and SM behavior among persons with mild-to-moderate COPD in Wenzhou, China. Methods A simple random sampling technique was used to recruit 121 persons with mild-to-moderate COPD who visited the respiratory outpatient department of the First Affiliated Hospital of Wenzhou Medical University in Wenzhou, China. Research instruments include a demographic data questionnaire, COPD SM scale, COPD knowledge questionnaire, 6-item chronic disease self-efficacy scale, and perceived social support scale. Descriptive statistics and Pearson’s Correlation were used for data analysis. Results The findings show that the mean score of COPD SM scale was 2.70 (SD = 0.45). The Pearson correlation analysis revealed that the COPD knowledge (r = 0.47, P < 0.001), self-efficacy (r = 0.28, P = 0.001), and perceived social support (r = 0.48, P < 0.001) were positively correlated to the COPD SM behavior among persons with mild-to-moderate COPD in Wenzhou, China. Conclusions The findings indicate that disease knowledge, self-efficacy, and perceived social support were related to SM behavior in persons with mild-to-moderate COPD, which provides a theoretical basis for developing SM interventions for persons with mild-to-moderate COPD and improving this population’s SM behavior.

show abstract

Section: Copd Sm Behavior Among Persons With Mild-to-moderate Copdmentioning

confidence: 99%

Factors related to self-management behavior among persons with mild-to-moderate chronic obstructive pulmonary disease in Wenzhou, China

Sheng,

Samartkit,

Masingboon

2023

Frontiers of Nursing

View full text Add to dashboard Cite

show abstract

“…When this is absent the treatment offered may be suboptimal. Improved care coordination is needed to overcome this treatment burden [ 30 ]. In this section, the most prominent issues about the current organisation of respiratory treatments and the related care coordination solutions will be described.…”

Section: The Burden Of Respiratory Treatmentsmentioning

confidence: 99%

Patient's treatment burden related to care coordination in the field of respiratory diseases

Pierucci

Santomasi

Ambrosino

et al. 2021

Breathe

View full text Add to dashboard Cite

The management of respiratory diseases requires various levels of care: multidisciplinary teams, educational and behavioural interventions, self-management and home-based technical support are vital to ensure adequate care management. However, it is often difficult to access these networks due to fragmentation of patient care and treatment burden. Care coordination aims to ensure patients have a central role and that there is continuity of care among various levels and professionals involved. Moreover, the coronavirus disease pandemic has caused strain on the global healthcare system, with care coordination becoming increasingly important in increasing the resilience of health systems, supporting healthcare professionals and ensuring the right treatment and adequate level of care for these patients.

show abstract

“…This burden limits the amount of time patients can spend on other daily activities, such as work, study, leisure, and social participation ( 4 ). Studies have also documented the negative consequences of treatment burden, such as poor treatment adherence, worsening clinical and health outcomes, reduced quality of life (QoL), and wasted resources ( 2 , 5 , 6 ).…”

Section: Introductionmentioning

confidence: 99%

“…Health care practitioners often consider efficacy and safety or tolerability (adverse events [AEs]) or the benefit‐to‐risk profile when choosing therapies but pay less attention to other aspects in which treatments affect the functionality and well‐being of patients, such as impact on QoL, barriers to access, and challenges when administering medications ( 5 ). Patients’ perspectives on treatment burden may not be captured in these typical safety/AE profiles that physicians consider when recommending or initiating a therapy.…”

Section: Introductionmentioning

confidence: 99%

Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study

Ogdie

Shaw

Almonte

et al. 2023

ACR Open Rheumatology

View full text Add to dashboard Cite

Objective To describe patients’ perspectives on the burden associated with methotrexate (MTX) or tumor necrosis factor inhibitor (TNFi) use in psoriatic arthritis (PsA) and rheumatoid arthritis (RA). Methods Between May 2019 and March 2020, patients receiving MTX and/or a TNFi for either PsA or RA were randomly sampled from the FORWARD data bank and were invited to participate in semistructured telephone interviews. Interviews explored patients’ perspectives on treatment burden and experiences with MTX and TNFi and were conducted until data saturation was achieved. Interviews were recorded, transcribed, and analyzed using a grounded theory approach and NVivo v12.0 software. Results Overall, 25 patients with PsA and 24 patients with RA participated in the interviews. Participants were predominantly women (mean age: 67 years). Nine major themes related to treatment burden were explored, including treatment side effects and their management, psychological burden, effect on daily functioning and work participation, challenges with accessing and administering therapies, financial difficulties or economic impact, and family planning or breastfeeding. Patients receiving MTX mostly reported side effects as the major burden, while cost and concerns with accessing and administering medication were major challenges reported by TNFi users. Treatment discontinuation due to lack of effectiveness was high for PsA, while discontinuation due to medication cost was high for RA. Conclusion Patients experience a wide range of burden associated with treatments used for PsA and RA. Health care practitioners should consider these challenges when prescribing therapy and strive toward reducing this burden by understanding patients’ concerns and needs and involving them in decision making.

show abstract

Treatment burden is important to patients but often overlooked by clinicians

Cited by 7 publications

References 14 publications

Factors related to self-management behavior among persons with mild-to-moderate chronic obstructive pulmonary disease in Wenzhou, China

Factors related to self-management behavior among persons with mild-to-moderate chronic obstructive pulmonary disease in Wenzhou, China

Patient's treatment burden related to care coordination in the field of respiratory diseases

Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study

Contact Info

Product

Resources

About